Lee Baer

17.7k total citations
208 papers, 12.8k citations indexed

About

Lee Baer is a scholar working on Clinical Psychology, Experimental and Cognitive Psychology and Cognitive Neuroscience. According to data from OpenAlex, Lee Baer has authored 208 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Clinical Psychology, 62 papers in Experimental and Cognitive Psychology and 54 papers in Cognitive Neuroscience. Recurrent topics in Lee Baer's work include Obsessive-Compulsive Spectrum Disorders (94 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (46 papers) and Treatment of Major Depression (41 papers). Lee Baer is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (94 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (46 papers) and Treatment of Major Depression (41 papers). Lee Baer collaborates with scholars based in United States, United Kingdom and Brazil. Lee Baer's co-authors include Michael A. Jenike, Scott L. Rauch, Cary R. Savage, William E. Minichiello, Sabine Wilhelm, Nancy J. Keuthen, David Mataix‐Cols, Maurizio Fava, Thilo Deckersbach and Richard O’Sullivan and has published in prestigious journals such as New England Journal of Medicine, JAMA and PLoS ONE.

In The Last Decade

Lee Baer

206 papers receiving 12.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lee Baer 8.7k 3.9k 3.6k 2.2k 1.1k 208 12.8k
José M. Menchón 8.9k 1.0× 3.9k 1.0× 2.7k 0.8× 2.2k 1.0× 730 0.7× 419 13.5k
Duncan B. Clark 5.7k 0.7× 2.3k 0.6× 2.5k 0.7× 2.0k 0.9× 1.2k 1.1× 252 13.4k
Miriam Gibbon 7.7k 0.9× 2.7k 0.7× 3.3k 0.9× 4.3k 2.0× 782 0.7× 15 13.6k
Anton J.L.M. van Balkom 6.7k 0.8× 3.0k 0.8× 4.9k 1.3× 2.2k 1.0× 703 0.6× 283 11.5k
E. Weiller 4.9k 0.6× 2.1k 0.5× 3.0k 0.8× 3.2k 1.5× 977 0.9× 40 10.8k
Alan N. Simmons 3.6k 0.4× 5.6k 1.5× 3.6k 1.0× 2.1k 0.9× 702 0.6× 208 11.4k
Patrícia Brandão Amorim 5.3k 0.6× 2.6k 0.7× 3.0k 0.8× 3.6k 1.6× 1.1k 1.0× 29 12.9k
Wai Tat Chiu 7.6k 0.9× 1.9k 0.5× 4.2k 1.2× 2.1k 1.0× 871 0.8× 34 13.4k
Franklin R. Schneier 6.2k 0.7× 1.9k 0.5× 6.4k 1.8× 1.3k 0.6× 653 0.6× 145 10.3k
Richard van Dyck 7.6k 0.9× 2.2k 0.6× 4.9k 1.4× 4.7k 2.1× 983 0.9× 218 15.8k

Countries citing papers authored by Lee Baer

Since Specialization
Citations

This map shows the geographic impact of Lee Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Baer more than expected).

Fields of papers citing papers by Lee Baer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Baer. The network helps show where Lee Baer may publish in the future.

Co-authorship network of co-authors of Lee Baer

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Baer. A scholar is included among the top collaborators of Lee Baer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Baer. Lee Baer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ionescu, Dawn F., Kate H. Bentley, Matthias Eikermann, et al.. (2018). Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Journal of Affective Disorders. 243. 516–524. 126 indexed citations
2.
Freeman, Marlene P., Lauren Fisher, Alisabet Clain, et al.. (2017). Differentiating Residual symptoms of Depression from Adverse Events among Patients Initiating Treatment with An Antidepressant. Annals of Clinical Psychiatry. 29(1). 28–34. 4 indexed citations
3.
Yeung, Albert, Peter M. Wayne, Gloria Y. Yeh, et al.. (2017). A Pilot, Randomized Controlled Study of Tai Chi With Passive and Active Controls in the Treatment of Depressed Chinese Americans. The Journal of Clinical Psychiatry. 78(5). e522–e528. 36 indexed citations
4.
Freeman, Marlene P., et al.. (2017). Guarding the Gate. Journal of Clinical Psychopharmacology. 37(2). 176–181. 23 indexed citations
5.
Yeung, Albert, Lee Baer, Justin A. Chen, et al.. (2016). The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants. The Journal of Clinical Psychiatry. 77(8). e996–e1002. 25 indexed citations
6.
Ionescu, Dawn F., Richard C. Shelton, Lee Baer, et al.. (2016). Ziprasidone augmentation for anxious depression. International Clinical Psychopharmacology. 31(6). 341–346. 8 indexed citations
7.
Mischoulon, David, Albert Yeung, Alisabet Clain, et al.. (2016). Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. Journal of Affective Disorders. 208. 6–14. 41 indexed citations
8.
Heo, Jung-Yoon, Hong Jin Jeon, Maurizio Fava, et al.. (2015). Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial. Journal of Psychiatric Research. 62. 56–61. 5 indexed citations
9.
Chen, Justin A., George I. Papakostas, Susannah R. Parkin, et al.. (2014). Association between physician beliefs regarding assigned treatment and clinical response: Re-analysis of data from the Hypericum Depression Trial Study Group. Asian Journal of Psychiatry. 13. 23–29. 11 indexed citations
10.
Cassano, Paolo, Trina Chang, Nhi‐Ha Trinh, et al.. (2013). Differential impact of isolated psychotic symptoms on treatment outcome of major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos. Journal of Affective Disorders. 150(2). 578–584. 12 indexed citations
11.
Papakostas, George I., Richard C. Shelton, John Zajecka, et al.. (2012). l -Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials. American Journal of Psychiatry. 169(12). 1267–1274. 182 indexed citations
12.
Farabaugh, Amy, Stella Bitran, Jonathan E. Alpert, et al.. (2010). Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome. International Clinical Psychopharmacology. 25(4). 214–217. 35 indexed citations
13.
Trinh, Nhi‐Ha, Irene Shyu, Patrick J. McGrath, et al.. (2010). Examining the role of race and ethnicity in relapse rates of major depressive disorder. Comprehensive Psychiatry. 52(2). 151–155. 4 indexed citations
14.
Baer, Lee. (2009). Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. Humana Press eBooks. 113 indexed citations
15.
Papakostas, George I., Alisabet Clain, Victoria Ameral, et al.. (2009). Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. International Clinical Psychopharmacology. 25(1). 17–21. 16 indexed citations
16.
Yang, Huaiyu, Sarah Chuzi, Ying Chen, et al.. (2009). Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. European Archives of Psychiatry and Clinical Neuroscience. 260(2). 145–150. 31 indexed citations
17.
Gershuny, Beth S., et al.. (2007). Trauma and posttraumatic stress disorder in treatment-resistant obsessive-compulsive disorder. Depression and Anxiety. 25(1). 69–71. 90 indexed citations
18.
Fava, Maurizio, Jonathan E. Alpert, Andrew A. Nierenberg, et al.. (2002). Double-Blind Study of High-Dose Fluoxetine Versus Lithium or Desipramine Augmentation of Fluoxetine in Partial Responders and Nonresponders to Fluoxetine. Journal of Clinical Psychopharmacology. 22(4). 379–387. 94 indexed citations
19.
Rauch, Scott L., Paul J. Whalen, Tim Curran, et al.. (2001). Probing striato-thalamic function in obsessive-compulsive disorder and Tourette syndrome using neuroimaging methods.. PubMed. 85. 207–24. 89 indexed citations
20.
Baer, Lee, et al.. (1998). Self-treatment for obsessive compulsive disorder using a manual and a computerized telephone interview: a U.S.-U.K. study.. PubMed. 15(3). 149–57. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026